Evidence map›Paper›PMID 39042271›Full record

ArticleActa neurochirurgica2024

Analysis of rescue strategies for acute thrombosis during STA-MCA bypass surgery and the literature review.

Haitao Xu, Haojin Ni, Chenhui Zhou, Xinwen Wang, Jie Wei, Tiansheng Qian, Zifeng Dai, Wenting Lan, Xin Wu, Jiacheng Yu and 4 more

Abstract read
In one paragraph

Article in Acta neurochirurgica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Haitao Xu *The First Affiliated Hospital, Health Science Center, Ningbo University, Ningbo, China.
Haojin Ni *The First Affiliated Hospital, Health Science Center, Ningbo University, Ningbo, China.
Chenhui Zhou *Department of Neurosurgery, Ningbo Key Laboratory of Nervous System and Brain Function, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315010, China.
Xinwen WangDepartment of Neurology, The First Affiliated Hospital of Ningbo University, Ningbo, China.
Jie WeiDepartment of Neurosurgery, Ningbo Key Laboratory of Nervous System and Brain Function, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315010, China.
Tiansheng QianDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China.
Zifeng DaiDepartment of Neurosurgery, Ningbo Key Laboratory of Nervous System and Brain Function, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315010, China.
Wenting LanDepartment of Radiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
Xin WuDepartment of Radiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
Jiacheng YuDepartment of Radiology, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
Xianru LiDepartment of Neurosurgery, Ningbo Key Laboratory of Nervous System and Brain Function, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315010, China.
Xiang GaoDepartment of Neurosurgery, Ningbo Key Laboratory of Nervous System and Brain Function, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315010, China. qinyuecui@163.com.
Bin XuDepartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai, China. xubinww@yahoo.com.
Jinghui LinDepartment of Neurosurgery, Ningbo Key Laboratory of Nervous System and Brain Function, The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, 315010, China. bpbpbbpp@126.com.

Funding

Medical Scientific Research Foundation of Zhejiang Province 2020ky820Medical Scientific Research Foundation of Zhejiang Province 2021ZA129Ningbo Health Branding Subject Fund (PPXK2018-04)Ningbo Top Medical and Health Research Program 2022020304Science and Technology Innovation 2025 Major Project of Ningbo 2022Z134Zhejiang Traditional Chinese Medicine Scientific Research Fund Project 2021ZA129Zhejiang Traditional Medicine and Technology Program 2020ZB216
6 · The paper itself

Abstract

BACKGROUND AND

objectivesSTA-MCA bypass surgery is mainly used for Moyamoya disease, giant intracranial aneurysms, and resection of intracranial tumors requiring sacrifice of blood vessels. The intraoperative patency of the reconstructive vessels is critical to the efficacy of the procedure. This study aimed to evaluate the efficacy of intra-arterially infused tirofiban for the treatment of acute thrombosis during STA-MCA bypass surgery and countermeasures for acute thrombosis.

methodsThis study involved 209 patients (272 hemispheres) who underwent STA-MCA surgery between November 2020 and December 2023. Intraoperative acute thrombosis occurred in eight patients (3.83%,8 hemispheres). We retrospectively reviewed the clinical and imaging data, surgical procedure, and follow-up outcomes of eight patients. We implemented the different thrombolytic methods to evaluate the optimal thrombosis management during the bypass surgery. After three months, we assessed neurological functions using the modified Rankin Scale (mRS) and conducted a literature review using PubMed.

resultsEight patients (four male patients and four female patients) developed acute thrombosis during the bypass surgery. Of the eight patients, two underwent re-anastomosis after thrombus removal, three received local injections of tirofiban into the anastomosis or the branches of the superficial temporal artery, and three underwent superselective intra-arterial tirofiban infusion using a microcatheter. Thrombosis were resolved, and arteries were recanalized in all patients. The mRS score was 0 in all patients. No major ischemic or hemorrhagic complications occurred.

conclusionOur treatment methods were efficacious in the management of acute thrombosis. Intra-arterial tirofiban administration seems to be a simple and effective treatment option for acute thrombosis during STA-MCA bypass surgery.

Indexed as

Cerebral RevascularizationTirofibanAdultFemaleFibrinolytic AgentsHumansIntraoperative ComplicationsMaleMiddle AgedMiddle Cerebral ArteryRetrospective StudiesTemporal ArteriesThrombolytic TherapyThrombosisTreatment OutcomeFibrinolytic AgentsTirofibanAcute thrombosisBypassMoyamoya diseaseTirofiban

Identifiers

PMID39042271
PMCPMC11266200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.